GSK's Linerixibat MAA Accepted By EMA For PBC-Associated Itch
23/6 16:25
(RTTNews) - GSK plc (GSK), Monday confirmed that the European Medicines Agency has accepted its marketing authorisation application for linerixibat, an investigational ileal bile acid transporter inhibitor, to treat cholestatic pruritus in primary biliary cholangitis. The submiss...